440 filings
Page 15 of 22
8-K
mit3 x1ntr6yvydk7
9 Mar 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
9wtwlbvk2q
22 Feb 18
ContraVir Pharmaceuticals Announces TXL™ Has Been Granted Orphan Drug Designation
12:00am
8-K
18rbix4y
21 Feb 18
3 of 4 Proposals pass with stockholder approval
12:00am
DEFA14A
dx8bel3
21 Feb 18
Additional proxy soliciting materials
12:00am
8-K
7idsu5w68l4
12 Feb 18
ContraVir Pharmaceuticals Reaches Agreement with the FDA on the NDA Package for TXL™ Leveraging the 505(b)(2) Regulatory Pathway
12:00am
8-K
6ifsy29416ey3c7m
9 Feb 18
ContraVir Pharmaceuticals to Present at BIO CEO & Investor Conference
12:00am
8-K
788ymb4h
6 Feb 18
Other Events
12:00am
8-K
crincq o6r
5 Feb 18
ContraVir Pharmaceuticals Receives Positive Nasdaq Listing Determination
12:00am
8-K
g1n 86dr0h
3 Jan 18
ContraVir Pharmaceuticals to Present at Biotech Showcase 2018
12:00am
8-K
ypfpn2jln8te
2 Jan 18
Other Events
12:00am
8-K
zahy2v5y8i
21 Dec 17
Other Events
12:00am
8-K
llh ry14t
18 Dec 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
w7zii38
13 Dec 17
Other Events
12:00am
DEFA14A
9jfvkcte 0s791im
13 Dec 17
Additional proxy soliciting materials
12:00am
8-K
m8or25qbnh4h7w
8 Dec 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
DEFA14A
6r211hk9 xlnl
6 Dec 17
Additional proxy soliciting materials
12:00am
8-K
uvywj fqbvzpc
6 Nov 17
ContraVir Pharmaceuticals to Receive Non-Dilutive Funding through New Jersey Technology Business Tax Certificate Transfer (NOL) Program
12:00am